| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/26/2023 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Sold 75,000 shares
@ $1.89, valued at
$141.8k
|
|
| 02/14/2022 |
SC 13G/A
| ROCHE FINANCE LTD reports a 1.1% stake in Tempest Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| ROCHE FINANCE LTD reports a 4.4% stake in Vaxcyte, Inc. |
| 02/14/2022 |
SC 13G
| ROCHE FINANCE LTD reports a 9% stake in Entrada Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| ROCHE FINANCE LTD reports a 4.8% stake in Allakos Inc. |
| 02/14/2022 |
SC 13G/A
| ROCHE FINANCE LTD reports a 5.8% stake in Eloxx Pharmaceuticals, Inc. |
| 11/04/2021 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Converted 2,495,385 shares
@ $0
Converted 318,140 shares
@ $0
Converted 2,495,385 preferred shares
@ $0
Converted 318,140 preferred shares
@ $0 |
|
| 10/28/2021 |
3
| ROCHE HOLDING LTD (10% Owner) has filed a Form 3 on Entrada Therapeutics, Inc. |
| 10/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/04/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/14/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/02/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| ROCHE FINANCE LTD reports a 8.1% stake in Aligos Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/17/2020 |
SC 13G/A
| ROCHE FINANCE LTD reports a 6.2% stake in Millendo Therapeutics, Inc. |
| 12/17/2018 |
SC 13G
| ROCHE FINANCE LTD reports a 5.9% stake in Millendo Therapeutics, Inc. |
| 08/02/2018 |
4
| ROCHE HOLDINGS INC (10% Owner) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Bought 13,877,949 shares
@ $137, valued at
$1901.3M
Bought 2,343,078 shares
@ $137, valued at
$321M
|
|
| 07/23/2018 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Allakos Inc.|
Txns:
| Converted 4,610,723 shares
@ $0
Converted 4,108,091 options to buy
@ $0
Converted 502,632 options to buy
@ $0 |
|
| 07/18/2018 |
3
| ROCHE HOLDING LTD (10% Owner) has filed a Form 3 on Allakos Inc. |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/05/2017 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities [Amend] |
| 06/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/07/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/17/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 02/10/2014 |
SC 13G
| ROCHE FINANCE LTD reports a 9% stake in Ambit Biosciences Corporation |